Skip to main content
. Author manuscript; available in PMC: 2023 Nov 4.
Published before final editing as: ACS Nano. 2022 May 4:acsnano.2c02794. doi: 10.1021/acsnano.2c02794

Figure 2. Anti-RBD and anti-N-protein levels in donors’ sera.

Figure 2.

A) anti-RBD and anti-N-protein antibody (IgG) levels (geometric mean fluorescence intensity gMFI, average of 3 technical replicates) by flow cytometry-based immunoassay (Methods); B) comparison of anti-RBD IgG levels in 3 donor groups (full statistical analysis in Supplemental Table 1; n=10 vaccinated, 10 convalescent and 11 naïve donors; ***p<0.001; ****p<0.0001).